Scientific article
English

Increasing occurrence of atypical femoral fractures associated with bisphosphonate use

Published inArchives of internal medicine, vol. 172, no. 12, p. 930-936
Publication date2012
Abstract

Current evidence suggests that there is an association between bisphosphonate therapy and atypical femoral fractures, but the extent of this risk remains unclear.

Keywords
  • Adrenal Cortex Hormones/therapeutic use
  • Aged
  • Aged, 80 and over
  • Bone Density Conservation Agents/adverse effects
  • Case-Control Studies
  • Diphosphonates/adverse effects
  • Female
  • Femoral Fractures/epidemiology/etiology/radiography
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Odds Ratio
  • Risk
  • Sex Factors
  • Time Factors
  • Vitamin D/therapeutic use
Citation (ISO format)
MEIER, Raphaël et al. Increasing occurrence of atypical femoral fractures associated with bisphosphonate use. In: Archives of internal medicine, 2012, vol. 172, n° 12, p. 930–936. doi: 10.1001/archinternmed.2012.1796
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0003-9926
571views
0downloads

Technical informations

Creation05/28/2013 4:35:00 PM
First validation05/28/2013 4:35:00 PM
Update time03/14/2023 8:18:31 PM
Status update03/14/2023 8:18:31 PM
Last indexation10/30/2024 9:39:19 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack